` ABBOTINDIA (Abbott India Ltd) vs BSE Sensex 30 Comparison - Alpha Spread

ABBOTINDIA
vs
BSE Sensex 30

Over the past 12 months, ABBOTINDIA has outperformed BSE Sensex 30, delivering a return of 13% compared to the BSE Sensex 30's 6% growth.

Stocks Performance
ABBOTINDIA vs BSE Sensex 30

Loading
ABBOTINDIA
BSE Sensex 30
Add Stock

Performance Gap
ABBOTINDIA vs BSE Sensex 30

Sign Up to see
Performance Gap
Sign In
Sign Up

Performance By Year
ABBOTINDIA vs BSE Sensex 30

Loading
ABBOTINDIA
BSE Sensex 30
Add Stock

Competitors Performance
Abbott India Ltd vs Peers

BSE Sensex 30
ABBOTINDIA
LLY
JNJ
NOVO B
ROG
Add Stock

Abbott India Ltd
Glance View

Economic Moat
Narrow
Market Cap
631.2B INR
Industry
Pharmaceuticals

Abbott India Ltd., a subsidiary of the global healthcare conglomerate Abbott Laboratories, operates as a key player in India’s pharmaceutical landscape. Nestled in the vibrant, ever-evolving Indian market, Abbott India has carved a niche for itself with a strategic focus on both innovation and localization. Its operations span the development, manufacture, and sale of a wide array of pharmaceutical products. By leveraging Abbott's global expertise and its deep understanding of local market dynamics, the company designs solutions catered to the unique health challenges faced by Indian consumers. Their product portfolio includes a diverse range of proprietary medicines, nutrition products, diagnostics, and branded generics, which address therapeutic areas like cardiology, women's health, gastroenterology, and metabolic disorders. Abbott India’s revenue engine primarily hinges on its extensive distribution networks and its substantial investments in research and development aimed at optimizing treatment paradigms. The company employs a customer-centric approach, working closely with healthcare professionals to ensure the accessibility of its medications across the country. By aligning its operations with the latest trends in healthcare needs and regulatory requirements, Abbott India ensures it remains at the forefront of serving its consumers efficiently. Its commitment to quality and continuous product improvement not only strengthens its market position but also fuels its growth trajectory in the Indian pharmaceutical sector, making it a formidable entity poised for sustained success in a dynamic industry.

ABBOTINDIA Intrinsic Value
HIDDEN
Show
Back to Top